Janney Montgomery Scott Upgrades Sarepta Therapeutic (SRPT) to Buy
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $18.95 -8.94%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Janney Montgomery Scott upgraded Sarepta Therapeutic (NASDAQ: SRPT) from Neutral to Buy with a price target of $65.00.
For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.
Shares of Sarepta Therapeutic closed at $28.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BNP Paribas Exane Upgrades Banco de Sabadell SA (SAB:SM) (BNDSF) to Outperform
- Goldman Sachs Upgrades BNK Financial Group (138930:KS) to Buy
- Jefferies Upgrades Valeo SA (FR:FP) (VLEEY) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Janney Montgomery ScottSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
